BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that management ...
today announced that the company will be participating in the upcoming Stifel 2024 HealthcareConference. AtriCure’s management is scheduled to participate in a fireside chat on Monday ...
Some results have been hidden because they may be inaccessible to you